文献速递母胎医学产科

扩展性无创产前检测的检测性能与临床实用性:单中心71,883例未选择性常规病例的经验

Test performance and clinical utility of expanded non-invasive prenatal test: Experience on 71,883 unselected routine cases from one single center.
PubMed 文献 · Prenat Diagn · 2024-04-30

本研究在单中心2年内对超过70,000例未选择性孕妇应用全基因组无创产前检测(GW-NIPT),采用统一流程和内部算法分析数据,回顾性审查临床结局。71,883例合格病例中1,011例(1.4%)获阳性结果,781例经侵入性产前诊断确诊;常见三体的临床敏感性为99.65%,微缺失为83.33%,各类胎儿异常的 specificity 均保持99.98%。

要点

  • 在71,883例未选择性病例中,GW-NIPT阳性率为1.4%(1,011例),其中781例经侵入性产前诊断确诊。
  • 常见三体(T21、T18、T13)的临床敏感性为99.65%,微缺失为83.33%。
  • 所检测的每一类胎儿异常的特异性均为99.98%。

核心结论

  • 将标准化流程与内部算法整合可减少不一致结果,获得高准确性;观察到的全基因组染色体状况检测可靠性强化了扩展性NIPT在临床实践中的效用。

研究设计与样本

  • 单中心、未选择性临床病例的回顾性研究,2年内超过70,000例孕妇接受GW-NIPT,所有样本统一采用Veriseq NIPT Solution v2处理并用自制算法分析测序数据,结果回顾性审查临床结局。

主要发现

  • 71,883例合格病例(包括双胎妊娠)中,1,011例(1.4%)获得阳性结果,781例经侵入性产前诊断确诊。
  • 常见三体(T21、T18、T13)的临床敏感性为99.65%,微缺失的临床敏感性为83.33%。
  • 所检测的每一类胎儿异常的特异性均为99.98%。

关键数值与推荐

  • GW-NIPT检测目标包括胎儿常见三体、性染色体非整倍体、罕见常染色体非整倍体、片段性异常(CNVs ≥ 7 Mb)和微缺失(CNVs < 7 Mb)。
  • 常见三体(T21、T18、T13)临床敏感性99.65%,微缺失临床敏感性83.33%。
  • 每一类胎儿异常检测特异性均为99.98%。

临床怎么用

  • 原文结论认为,整合标准化流程与内部算法可减少不一致结果并获得高准确性,扩展性NIPT在全基因组染色体状况检测中的可靠性支持其在临床实践中的效用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The balance between benefits and risks of discordant outcomes makes the Genome-Wide Non-Invasive Prenatal Test (GW-NIPT) controversial. This study aims to evaluate performance and clinical utility in a wide cohort of unselected clinical cases from a single center when a standardized protocol is applied and integrated with a secondary algorithm for data interpretation. METHOD: In 2 years, over 70,000 pregnant patients underwent GW-NIPT for fetal common trisomies, sex chromosome aneuploidies, rare autosomal aneuploidies, segmental abnormalities (CNVs ≥ 7 Mb) and microdeletions (CNVs < 7 Mb). All samples were uniformly processed with Veriseq NIPT Solution v2 and analyzed using all data metrics along with a home-made algorithm for sequencing data analysis. Results were retrospectively reviewed for clinical outcomes. RESULTS: Among 71,883 eligible cases including twin pregnancies, 1011 (1.4%) received a positive result and 781 were confirmed by invasive prenatal diagnosis. Clinical sensitivity ranged from 99.65% for common trisomy (T21, T18, T13) to 83.33% for microdeletions, while specificity remained high (99.98%) for each class of fetal abnormalities detected. CONCLUSIONS: Integrating a standardized protocol with an internal algorithm allowed discordant results to be reduced, yielding high accuracy. Observed reliability in detecting genome-wide chromosomal conditions reinforced the expanded NIPT utility in clinical practice.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Faieta M, Falcone R, Duca S, et al. Test performance and clinical utility of expanded non-invasive prenatal test: Experience on 71,883 unselected routine cases from one single center. Prenat Diagn. 2024. PMID: 38686956. doi:10.1002/pd.6580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。